The invention relates to a bioreactor system, and in particular to a bioreactor system enabling continuous and closed operation of inoculation, cultivation, and harvest of anchorage-dependent cells.
Generally, tissue engineering reconstruction, stem cell clinical application, protein pharmaceutical production, and cell treatment require a considerable number of animal cells. Cultivation and production of sufficient cells thus play an important role in the aforementioned fields.
Accordingly, cultivation and production of cells, such as anchorage-dependent cells, can be accomplished both statically and dynamically. In static cultivation, the anchorage-dependent cells are directly inoculated into a porous carrier. The porous carrier is then placed in a Petri dish and a cultivation solution is filled therein. The anchorage-dependent cells can thus proliferate in the porous carrier. Nevertheless, because of the limited volume of a Petri dish, numerous Petri dishes are required for proliferation of the anchorage-dependent cells. Moreover, as inoculation of the anchorage-dependent cells, replacement of the cultivation solution, and harvest of the anchorage-dependent cells require manual operations, a number of operators and much cultivation space are required. Further, the anchorage-dependent cells are easily contaminated by the aforementioned manual operation and cultivation.
To avoid the aforementioned problems in static cultivation, the anchorage-dependent cells can be instead cultivated dynamically. Namely, high-density cultivation of the anchorage-dependent cells can be performed in a bioreactor capable of providing sufficient metabolism and exchange of nutrients within a cultivation solution.
Referring to
Cultivation solution A and anchorage-dependent cells enter the reaction tank 11 via the input pipe 16. The cultivation solution A must completely cover the cell carrier 12. The stir blade 13 is driven by the motor 15 to stir the cultivation solution A in the reaction tank 11, attaching or inoculating the anchorage-dependent cells onto the cell carrier 12 and fully mixing the nutrients in the cultivation solution A. The anchorage-dependent cells can then proliferate in the cell carrier 12. After the anchorage-dependent cells are cultivated for a span of time, the cultivation solution A in the reaction tank 11 is discharged via the output pipe 17. At this point, the cell carrier 12 can be removed from the reaction tank 11 and enzyme, such as trypsin, can be applied to separate the anchorage-dependent cells from the cell carrier 12. Specifically, the cell carrier 12 is dissolved by the enzyme, such that the anchorage-dependent cells can be separated therefrom. The mixed solution including the anchorage-dependent cells and enzyme is then placed on a centrifuge, whereby the anchorage-dependent cells are separated from the enzyme. Accordingly, the proliferated anchorage-dependent cells can be obtained.
The bioreactor 1, however, has many drawbacks in cultivation of the anchorage-dependent cells (or cells). As the anchorage-dependent cells are inoculated in the cell carrier 12 by stirring, the inoculation rate thereof is reduced following increased volume of the reaction tank 11. To promote the inoculation rate of the anchorage-dependent cells, the proportion of the reaction tank 11 to the cell carrier 12 must be reduced. However, the reduced proportion of the reaction tank 11 to the cell carrier 12 indicates that the cultivation solution A is reduced, supplying few nutrients to the anchorage-dependent cells. Thus, the cultivation solution A must be frequently replaced. Moreover, to increase the amount of oxygen dissolved in the cultivation solution A, for the anchorage-dependent cells, the stirring speed of the stir blade 13 must be increased to enhance the exchange rate of air. The increased stirring speed of the stir blade 13, however, generates high shear force, causing the anchorage-dependent cells to separate from the cell carrier 12 and further death thereof. The proliferation of the anchorage-dependent cells is thus adversely affected. Furthermore, when the proliferated anchorage-dependent cells are harvested, the reaction tank 11 must be opened to remove the cell carrier 12, thereby contaminating the anchorage-dependent cells therein.
Hence, there is a need for a bioreactor system enabling continuous and closed operation of inoculation, cultivation, and harvest of cells, such as anchorage-dependent cells. Labor cost, and contamination of the cells (anchorage-dependent cells) can thus be reduced.
Accordingly, an exemplary embodiment of the invention provides a bioreactor system comprising a supply container and a bioreactor container. The supply container receives a cultivation solution. The bioreactor container is connected to the supply container and comprises a porous carrier. The porous carrier carries a plurality of cells. The cultivation solution circulates between the supply container and the bioreactor container, providing required nutrients to the cells.
The bioreactor system further comprises a motor disposed on the supply container.
The bioreactor system further comprises a stir blade disposed in the supply container and connected to the motor to agitate the cultivation solution.
The cells comprise anchorage-dependent cells.
The bioreactor system further comprises a first transportation pipe and a second transportation pipe respectively connected between the supply container and the bioreactor container. The cultivation solution flows from the supply container into the porous carrier of the bioreactor container via the first transportation pipe. The cultivation solution flows from the bioreactor container into the supply container via the second transportation pipe.
The bioreactor system further comprises a dissolution container connected to the first transportation pipe and receiving a dissolution. The dissolution flows into the porous carrier of the bioreactor container via the first transportation pipe, dissolving the porous carrier.
The bioreactor system further comprises a first peristaltic pump connected to the first transportation pipe. The cultivation solution flows into the porous carrier of the bioreactor container by operation of the first peristaltic pump.
The bioreactor system further comprises a second peristaltic pump connected to the second transportation pipe. The cultivation solution flows into the supply container by operation of the second peristaltic pump.
The bioreactor system further comprises a third transportation pipe connected between the first and second transportation pipes. The dissolution container is connected to the first transportation pipe between the bioreactor container and the third transportation pipe. The first peristaltic pump is connected to the first transportation pipe between the third transportation pipe and the supply container. The second peristaltic pump is connected to the second transportation pipe between the bioreactor container and the third transportation pipe.
The bioreactor system further comprises a first control valve, a second control valve, a third control valve, and a fourth control valve. The first control valve is connected to the first transportation pipe between the third transportation pipe and the first peristaltic pump. The second control valve is connected to the second transportation pipe between the third transportation pipe and the supply container. The third control valve is connected to the third transportation pipe. The fourth control valve is connected between the dissolution container and the first transportation pipe.
The bioreactor container further comprises a container body, an input pipe, and an output pipe. The porous carrier, input pipe, and output pipe are disposed in the container body. The porous carrier surrounds the input and output pipes. The input pipe is connected to the first transportation pipe and comprises a plurality of orifices on the pipe wall thereof. The output pipe is connected to the second transportation pipe. The cultivation solution flows into the porous carrier via the orifices of the input pipe. The cultivation solution flows out of the bioreactor container via the output pipe.
The output pipe is disposed in and extends outside the input pipe.
The orifices have different sizes and are uniformly formed on the pipe wall of the input pipe from smallest to largest.
The orifices have the same size and are formed on the pipe wall of the input pipe from sparse to dense.
The bioreactor container further comprises a container body, a first input pipe, a second input pipe, a third input pipe, and an output pipe. The porous carrier, first input pipe, second input pipe, third input pipe, and output pipe are disposed in the container body. The porous carrier surrounds the first input pipe, second input pipe, third input pipe, and output pipe. The caliber of the second input pipe is less than that of the first input pipe. The caliber of the third input pipe is less than that of the second input pipe. The first input pipe is connected to the first transportation pipe. The second input pipe is coaxially connected to the first input pipe. The third input pipe is coaxially connected to the second input pipe. The output pipe is connected to the second transportation pipe. The cultivation solution flows into the porous carrier via the first, second, and third input pipes. The cultivation solution flows out of the bioreactor container via the output pipe.
The output pipe is coaxially disposed in the first, second, and third input pipes and extends beyond the first and third input pipes.
The bioreactor system further comprises a sensor disposed in the supply container to detect the condition of the cultivation solution and concentration of oxygen dissolved therein.
The supply container further comprises an opening through which the cultivation solution and air flow into and out of the supply container.
The container body comprises a centrifugal tube.
The dissolution container comprises a syringe.
The porous carrier comprises alginate, N,O-carboxymethyl chitosan, or carboxymethyl cellulose.
The dissolution comprises EDTA (ethylenediminetetra acetic acid), sodium citriate, or EGTA (ethyleneglycol-bis (2-aminoethylether)-N′,N′,N′,N′-tetraactic acid).
The invention can be more fully understood by reading the subsequent detailed description and examples with references made to the accompanying drawings, wherein:
Referring to
As shown in
The bioreactor container 140 is connected to the supply container 110. Specifically, the bioreactor container 140 is connected to the supply container 110 by the first transportation pipe 160 and second transportation pipe 170. As shown in
As shown in
The container body 149 of the bioreactor container 140 may be a centrifugal tube, and the dissolution container 150 may be a syringe. The porous carrier B disposed in the bioreactor container 140 may comprise alginate, N,O-carboxymethyl chitosan, or carboxymethyl cellulose. The dissolution C may comprise EDTA (ethylenediminetetra acetic acid), sodium citriate, or EGTA (ethyleneglycol-bis (2-aminoethylether)-N′,N′,N′,N′-tetraactic acid).
The following description is directed to cultivation of anchorage-dependent cells using the bioreactor system 100.
As shown in
In another aspect, the motor 120 activates the stir blade 130. The cultivation solution A input to the supply container 110 via the opening 111 is agitated by the stir blade 130, aerating the cultivation solution A, increasing the concentration of oxygen dissolved therein.
After the anchorage-dependent cells are inoculated in the porous carrier B, the third control valve 181 and fourth control valve 151 remain closed and the first control valve 162 and second control valve 172 remain open. The first peristaltic pump 161 and second peristaltic pump 171 are simultaneously activated. At this point, the cultivation solution A circulates between the supply container 110 and the bioreactor container 140, continuously cultivating the anchorage-dependent cells in the porous carrier B of the bioreactor container 140. Specifically, the cultivation solution A in the supply container 110 flows into the input pipe 141 via the first transportation pipe 160. Then, the cultivation solution A uniformly flows into the porous carrier B via the orifices 143 on the input pipe 141, proliferating the anchorage-dependent cells. Moreover, the cultivation solution A containing metabolite of the anchorage-dependent cells flows to the bottom of the bioreactor container 140 and further into the supply container 110 via the output pipe 142 and second transportation pipe 170 to mix with the cultivation solution A therein. Accordingly, the anchorage-dependent cells in the porous carrier B are continuously supplied with the cultivation solution A containing needed nutrients and oxygen.
In another aspect, when nutrients in the cultivation solution A are insufficient, the cultivation solution A can be drawn out via the opening 111 of the supply container 110. Fresh cultivation solution A can then be input to the supply container 110 via the opening 111 thereof. Similarly, the fresh cultivation solution A circulates between the supply container 110 and the bioreactor container 140 to perfuse the porous carrier B and cultivate the anchorage-dependent cells therein.
After proliferation of the anchorage-dependent cells is complete, the first control valve 162, first peristaltic pump 161, third control valve 181, and fourth control valve 151 remain closed and the second control valve 172 and second peristaltic pump 171 remain open. At this point, the cultivation solution A in the bioreactor container 140 is drawn to the supply container 110. Then, the second control valve 172, second peristaltic pump 171, first control valve 162, third control valve 181, and first peristaltic pump 161 remain closed and the fourth control valve 151 remains open. The dissolution C in the dissolution container 150 is completely input to the bioreactor container 140 via the first transportation pipe 160 and input pipe 141. Then, the fourth control valve 151, first control valve 162, second control valve 172, and first peristaltic pump 161 remain closed and the second peristaltic pump 171 and third control valve 181 remain open. At this point, the dissolution C circulates in the bioreactor container 140 until the porous carrier B disposed therein is completely dissolved. The second peristaltic pump 171 and third control valve 181 are then closed and the bioreactor container 140 is separated from the first transportation pipe 160 and second transportation pipe 170. The bioreactor container 140 can be placed on a centrifuge and the proliferated anchorage-dependent cells are separated from the dissolution C thereby.
Elements corresponding to those in the first embodiment share the same reference numerals.
Referring to
Structure, disposition, and function of other elements of the bioreactor system 100′ are the same as those of the bioreactor system 100, and explanation thereof is omitted for simplicity.
The following description is directed to cultivation of anchorage-dependent cells using the bioreactor system 100′.
As shown in
Similarly, the motor 120 activates the stir blade 130. The cultivation solution A input to the supply container 110 via the opening 111 is agitated by the stir blade 130, aerating the cultivation solution A, increasing the concentration of oxygen dissolved therein.
After the anchorage-dependent cells are inoculated in the porous carrier B, the third control valve 181 and fourth control valve 151 remain closed and the first control valve 162 and second control valve 172 remain open. The second peristaltic pump 171 is activated. At this point, the cultivation solution A circulates between the supply container 110 and the bioreactor container 140, continuously cultivating the anchorage-dependent cells in the porous carrier B of the bioreactor container 140. Specifically, the cultivation solution A in the supply container 110 flows into the input pipe 141 via the first transportation pipe 160. Then, the cultivation solution A uniformly flows into the porous carrier B via the orifices 143 on the input pipe 141, proliferating the anchorage-dependent cells. Moreover, the cultivation solution A containing metabolite of the anchorage-dependent cells flows to the bottom of the bioreactor container 140 and further into the supply container 110 via the output pipe 142 and second transportation pipe 170 to mix with the cultivation solution A therein. Accordingly, the anchorage-dependent cells in the porous carrier B are continuously supplied with the cultivation solution A containing needed nutrients and oxygen. Specifically, the bioreactor container 140 is connected outside by only the second transportation pipe 170 and first transportation pipe 160 and is completely sealed. Accordingly, as the bioreactor container 140 is completely sealed and has a fixed volume, the amount of the cultivation solution A flowing into the bioreactor container 140 via the second transportation pipe 170 is the same as that flowing out of the bioreactor container 140 via the first transportation pipe 160. When the third control valve 181 and fourth control valve 151 remain closed and the first control valve 162 and second control valve 172 remain open, the second transportation pipe 170, first transportation pipe 160, and bioreactor container 140 can be regarded as a closed system. Namely, as the inside volume of the bioreactor container 140 is fixed, the amount of cultivation solution A transported from the supply container 110 to the bioreactor container 140 by the second peristaltic pump 171 equals that expelled from the bioreactor container 140 to the supply container 110. Accordingly, the volume or height of the cultivation solution A in the bioreactor container 140 is thus fixed. Namely, the amount of the cultivation solution A in the bioreactor container 140 is not changed with time.
Similarly, when nutrients in the cultivation solution A are insufficient, the cultivation solution A can be drawn out via the opening 111 of the supply container 110. Fresh cultivation solution A can then be input to the supply container 110 via the opening 111 thereof. Similarly, the fresh cultivation solution A circulates between the supply container 110 and the bioreactor container 140 to perfuse the porous carrier B and cultivate the anchorage-dependent cells therein.
After proliferation of the anchorage-dependent cells is complete, the first control valve 162, third control valve 181, and fourth control valve 151 remain closed and the second control valve 172 and second peristaltic pump 171 remain open. At this point, the cultivation solution A in the bioreactor container 140 is drawn to the supply container 110. Then, the second control valve 172, second peristaltic pump 171, first control valve 162, and third control valve 181 remain closed and the fourth control valve 151 remains open. The dissolution C in the dissolution container 150 is completely input to the bioreactor container 140 via the first transportation pipe 160 and input pipe 141. Then, the fourth control valve 151, first control valve 162, and second control valve 172 remain closed and the second peristaltic pump 171 and third control valve 181 remain open. At this point, the dissolution C circulates in the bioreactor container 140 until the porous carrier B disposed therein is completely dissolved. The second peristaltic pump 171 and third control valve 181 are then closed and the bioreactor container 140 is separated from the first transportation pipe 160 and second transportation pipe 170. The bioreactor container 140 can be placed on a centrifuge and the proliferated anchorage-dependent cells are separated from the dissolution C thereby.
Moreover, in the aforementioned embodiments, the disclosed bioreactor container is not limited to the structure shown in
As shown in
Accordingly, the input pipe 141′ and an output pipe 142 of the bioreactor container 140′ are respectively connected to the first transportation pipe 160 and second transportation pipe 170. The cultivation solution A uniformly flows into or perfuses the porous carrier B via the orifices 143′ on the input pipe 141′, proliferating the anchorage-dependent cells. Moreover, the cultivation solution A containing metabolite of the anchorage-dependent cells flows to the bottom of the bioreactor container 140′ and further flows into the supply container 110 via the output pipe 142 and second transportation pipe 170 to mix with the cultivation solution A therein.
As shown in
Accordingly, the first input pipe 144 and output pipe 142 of the bioreactor container 140″ are respectively connected to the first transportation pipe 160 and second transportation pipe 170. The cultivation solution A uniformly flows into or perfuses the porous carrier B via the first input pipe 144, second input pipe 145, and third input pipe 146, proliferating the anchorage-dependent cells. Moreover, the cultivation solution A containing metabolite of the anchorage-dependent cells flows to the bottom of the bioreactor container 140″ and further into the supply container 110 via the output pipe 142 and second transportation pipe 170 to mix with the cultivation solution A therein.
In conclusion, the disclosed bioreactor system has the following advantages. As the anchorage-dependent cells are inoculated in the porous carrier B by continuous perfusion, the present bioreactor system provides enhanced inoculation rate of cells (anchorage-dependent cells) compared to conventional bioreactors. Additionally, as the present bioreactor system provides an independent supply container supplying the cultivation solution, the amount of cultivation solution required for proliferation of the cells (anchorage-dependent cells) is not limited by the capacity of the bioreactor container, thereby eliminating the need for frequent replacement of the cultivation solution. Moreover, the present bioreactor system continuously provides the cells (anchorage-dependent cells) with cultivation solution containing increased concentration of oxygen dissolved therein, thereby successfully proliferating the cells (anchorage-dependent cells). Furthermore, as inoculation, cultivation, and harvest of the cells (anchorage-dependent cells) are continuously performed in the closed bioreactor system, operation labor and costs and contamination of the cells (anchorage-dependent cells) are thus reduced.
While the invention has been described by way of example and in terms of preferred embodiment, it is to be understood that the invention is not limited thereto. To the contrary, it is intended to cover various modifications and similar arrangements (as would be apparent to those skilled in the art). Therefore, the scope of the appended claims should be accorded the broadest interpretation so as to encompass all such modifications and similar arrangements.
Number | Date | Country | Kind |
---|---|---|---|
93141731 | Dec 2004 | TW | national |
94118164 | Jun 2005 | TW | national |